Source: Eur Respir J 2015; 45: 1539-1541



Rating:

Share or cite this content

Citations should be made in the following way:
Mathai Susan K., Schwartz David A.. Taking the “I” out of IPF. Eur Respir J 2015; 45: 1539-1541

Member's Comments

No comment yet.

Related content which might interest you: IPF or NSIP? That is the question Source: Eur Respir J 2003; 22: 191-192 Year: 2003 Collagen I, III and IV content in airways and lung parenchyma of COPD patients Source: Annual Congress 2010 - Proteases and the matrix Year: 2010 IPF Source: Eur Respir Monogr 2017; 77: 199-223 Year: 2017 IPF Source: Eur Respir Monogr 2017; 77: 58-65 Year: 2017 Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Transplantation of alveolar type II cells in pulmonary fibrosis: experimental studies, MSC in IPF trials Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 IPF: a distinct clinical entity? Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases" Year: 2017 Is GOLD stage 0 a good predictor of the development of COPD? Preliminary results from the ECRHS II Source: Eur Respir J 2005; 26: Suppl. 49, 434s Year: 2005 Fatigue in patients with idiopathic pulmonary fibrosis (IPF) from the pooled pirfenidone (PFD) Phase III trials Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Collagen degradation profile in serum of patients with COPD or IPF Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways Year: 2012 Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think? Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Analysis of pulmonary function in patients with idiopathic pulmonary fibrosis (IPF): how stable is stable IPF? Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 First insights from the BTS idiopathic pulmonary fibrosis (IPF) registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights Source: Eur Respir J, 58 (2) 2100920; 10.1183/13993003.00920-2021 Year: 2021 How are we going to treat IPF patients in the future? Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges Year: 2013 Idiopathic pulmonary fibrosis (IPF): observations from a Phase 2 trial of GLPG1205 (PINTA) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011